Literature DB >> 15270725

An investigation of the ability of orally primed and tolerised T cells to help B cells upon mucosal challenge.

Natalie Kobets1, Kim Kennedy, Deborah O'Donnell, Paul Garside.   

Abstract

The oral delivery of soluble antigens induces unresponsiveness to systemic challenge that can be demonstrated as a reduced ability of tolerised T cells to support B-cell expansion and antibody production. However, it remains controversial whether previously induced oral tolerance results in suppression or priming, or has no effect on B-cell responses upon oral challenge. Using a double adoptive transfer system, we primed or tolerised T cells (independently of B cells) with a high dose of fed antigen, and examined the ability of these primed or tolerised T cells to support B-cell clonal expansion in response to orally delivered conjugated antigen. We demonstrated directly in vivo that, in contrast to orally primed T cells, transgenic T cells tolerised by feeding a high dose of antigen are incapable of providing cognate help to support B-cell clonal expansion and antibody production in response to oral challenge. This defect appears to be a result of a reduced ability of orally tolerised transgenic T cells to clonally expand and migrate to B-cell follicles after oral challenge.

Mesh:

Substances:

Year:  2004        PMID: 15270725      PMCID: PMC1782527          DOI: 10.1111/j.1365-2567.2004.01913.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

Review 1.  Vaccination by inducing oral tolerance?

Authors:  S J McSorley; P Garside
Journal:  Immunol Today       Date:  1999-12

2.  Orally tolerized T cells are only able to enter B cell follicles following challenge with antigen in adjuvant, but they remain unable to provide B cell help.

Authors:  Karen M Smith; Fiona McAskill; Paul Garside
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

Review 3.  Oral tolerance.

Authors:  P Garside; A M Mowat
Journal:  Semin Immunol       Date:  2001-06       Impact factor: 11.130

4.  T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division.

Authors:  Karen M Smith; Joanne M Davidson; Paul Garside
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

5.  Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo.

Authors:  K M Smith; L Pottage; E R Thomas; A J Leishman; T N Doig; D Xu; F Y Liew; P Garside
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

6.  Nasal vaccination induces protective immunity without immunopathology.

Authors:  T Hussell; I R Humphreys
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

7.  Visualization of specific B and T lymphocyte interactions in the lymph node.

Authors:  P Garside; E Ingulli; R R Merica; J G Johnson; R J Noelle; M K Jenkins
Journal:  Science       Date:  1998-07-03       Impact factor: 47.728

8.  Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.

Authors:  H Kato; K Fujihashi; R Kato; Y Yuki; J R McGhee
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

9.  IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin.

Authors:  M Cumberbatch; M Bhushan; R J Dearman; I Kimber; C E M Griffiths
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

10.  Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells.

Authors:  A Iwasaki; B L Kelsall
Journal:  J Exp Med       Date:  1999-07-19       Impact factor: 14.307

View more
  1 in total

1.  Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.

Authors:  Annie George Chandy; Susanne Hultkrantz; Sukanya Raghavan; Cecil Czerkinsky; Michael Lebens; Esbjörn Telemo; Jan Holmgren
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.